Exhibit 10.5
VIRACTA THERAPEUTICS, INC.
AMENDMENT TO EMPLOYMENT AGREEMENT
This Amendment to Employment Agreement (this “Amendment”) by and between Viracta Therapeutics, Inc. (the “Company”) and Daniel R. Chevallard, CPA (“Executive”) is effective as of August 12, 2021.
WHEREAS, the Company and Executive are parties to that certain Employment Agreement, effective as of July 29, 2019 (the “Original Agreement”); and
WHEREAS, the Company and Executive desire to amend the Original Agreement on the terms and conditions set forth below.
NOW, THEREFORE, in consideration of the mutual promises herein contained, the parties agree as follows:
2
Remainder of Page Intentionally Left Blank
3
IN WITNESS WHEREOF, each of the parties has executed this Amendment (in the case of the Company, by a duly authorized officer or director), effective as of the date set forth above.
COMPANY:
VIRACTA THERAPEUTICS, INC.
/s/ Ivor Royston
By: Ivor Royston, M.D.
Title: President & CEO
EXECUTIVE:
/s/ Daniel Chevallard
[SIGNATURE PAGE TO EMPLOYMENT AGREEMENT]
4